Literature DB >> 7260834

A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia.

A E Evans, J Chatten, G J D'Angio, J M Gerson, J Robinson, L Schnaufer.   

Abstract

The records of 207 neuroblastoma patients seen at the Children's Hospital of Philadelphia between 1944 and 1977 were reviewed to study some of the features associated with the unusually good prognosis found in patients with Stage IV-S neuroblastoma. Initially, 22 patients appeared to fit the criteria of small primary tumor and distant disease in liver, skin, and/or marrow without evidence of bone metastases; 5 patients were subsequently rejected as being incorrectly staged. The remaining 17 patients had abdominal primary tumors and hepatic disease; in 12 of the 17, an enlarged liver was the presenting sign. Six patients had skin lesions, 4 had disease in the marrow on routine smear, and additional sites of spread were pancreas and bowel serosa. The treatment given was not systematic, and it was not possible to correlate any specific form of therapy with a satisfactory outcome. Eleven of 17 patients survived; 6 of 11 survivors had spontaneous regression of all or part of their diseases, 5 of 6 who died received irradiation, chemotherapy, or both. Death usually occurred in the first month as a complication of the local disease; 1 patient succumbed to radiation nephritis. This study establishes that the special pattern of widespread neuroblastoma termed Stage IV-S does exist, and that is associated with a good prognosis. Careful consideration should be given before selecting treatment for the Stage IV-S child because spontaneous regression is likely to occur in most of them. In patients with rapidly enlarging livers, renal or pulmonary complications may develop because of liver bulk or coagulopathies. Treatment should be directed to the liver in these cases because distant metastases seldom supervene. Low-dose irradiation, mild chemotherapy, and possibly surgical release of intraabdominal pressure using a silastic patch have all been effective. Unfortunately, patients occasionally succumb to local disease in spite of these and more aggressive measures.

Entities:  

Mesh:

Year:  1980        PMID: 7260834     DOI: 10.1002/1097-0142(19800301)45:5<833::aid-cncr2820450502>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.

Authors:  Octavio Burgues; Samuel Navarro; Rosa Noguera; Antonio Pellín; Amparo Ruiz; Victoria Castel; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

2.  Histogenesis of the human adrenal medulla. An evaluation of the ontogeny of chromaffin and nonchromaffin lineages.

Authors:  M J Cooper; G M Hutchins; M A Israel
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 3.  Differential diagnosis and management of liver tumors in infants.

Authors:  Israel Fernandez-Pineda; Rosa Cabello-Laureano
Journal:  World J Hepatol       Date:  2014-07-27

Review 4.  Imaging of neuroblastoma: an overview.

Authors:  A Bousvaros; D R Kirks; H Grossman
Journal:  Pediatr Radiol       Date:  1986

Review 5.  Cellular kinetics of neuroblastoma and the role of surgery.

Authors:  Tatsuo Kuroda
Journal:  Pediatr Surg Int       Date:  2011-07-19       Impact factor: 1.827

6.  Abdominal, retroperitoneal and sacrococcygeal tumours of the newborn and the very young infant. Report from the Kiel Paediatric Tumour Registry.

Authors:  D Harms; D Schmidt; I Leuschner
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

7.  Resection of primary tumor in stage 4S neuroblastoma: a second study by the Italian Neuroblastoma Group.

Authors:  Stefano Avanzini; Isabella Buffoni; Anna Rita Gigliotti; Stefano Parodi; Irene Paraboschi; Alessandro Inserra; Patrizia Dall'Igna; Anna Maria Fagnani; Giuseppe Martucciello; Mario Lima; Umberto Caccioppoli; Alberto Garaventa; Massimo Conte; Claudio Granata; Angela Rita Sementa; Elisa Tirtei; Giovanni Erminio; Bruno De Bernardi
Journal:  Pediatr Surg Int       Date:  2020-10-29       Impact factor: 1.827

8.  Do infants with stage IV-S neuroblastoma need treatment?

Authors:  A E Evans; E Baum; R Chard
Journal:  Arch Dis Child       Date:  1981-04       Impact factor: 3.791

Review 9.  An infant with bilateral adrenal neuroblastoma found by mass-screening: report of a case.

Authors:  F Kawaguchi; K Nakada; H Kitagawa; T Fujioka; Y Kim; T Enami; M Kuwabara; M Wakisaka; N Yamate; H Chihara
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Malignant tumours in the neonate.

Authors:  A N Campbell; H S Chan; A O'Brien; C R Smith; L E Becker
Journal:  Arch Dis Child       Date:  1987-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.